Skip to main content

1 Result(s)

within F. Chast Remove this filter Biomedicine Remove this filter

and

  1. Article

    Open Access

    A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia

    To determine the maximum-tolerated dose (MTD), dose-limiting toxicities and pharmacokinetic of semisynthetic homoharringtonine (ssHHT), given as a twice daily subcutaneous (s.c.) injections for 9 days, in pati...

    V Lévy, S Zohar, C Bardin, A Vekhoff, D Chaoui, B Rio… in British Journal of Cancer (2006)

    Download PDF (155 KB) View Article